title: Treatment of Dentin Hypersensitivity Using Nano-Hydroxyapatite Pastes: A Randomized Three-Month Clinical Trial.
abstract: OBJECTIVE
  This randomized clinical trial tested the three-month desensitizing effect of two protocols using nano-hydroxyapatite formulations compared with Pro-Argin and fluoride varnish.
  
  
  METHODS
  Twenty-eight subjects with 137 teeth presenting dentin exposure with a minimal hypersensitivity of four on the visual analog scale (VAS) took part of this study. The subjects were randomly assigned to four groups: Desensibilize Nano-P paste (20% hydroxyapatite [HAP], potassium nitrate, and sodium fluoride [NaF]; 9000 ppm fluoride [F]); Desensibilize Nano-P associated with experimental home-care pastes (10% HA, potassium nitrate, and NaF; 900 ppm F); Pro-Relief professional paste (8% arginine with Pro-Argin technology) associated with home-care toothpaste (8% arginine, sodium monofluorophosphate, 1450 ppm F); and Duraphat professional varnish (NaF varnish, 22,600 ppm F). The professional treatments were performed in weekly appointments over three weeks. The home-care products were used continuously for three months. A VAS was used to assess the tooth sensitivity response after standardized evaporative stimulus at baseline and after one month and three months. The baseline score was deducted from the final score, and the means were analyzed using nested analysis of variance, while the comparison between times was performed by a general linear model (p<0.05).
  
  
  RESULTS
  At the first month all treatments were effective, but there were no significant differences among them (p=0.94). At the third month, despite the fact that NaF varnish had the lowest effect in reducing hypersensitivity, no significant difference was found among the treatments (p=0.09). Only Pro-Relief increased its effect over time (p=0.049).
  
  
  CONCLUSIONS
  Nano-hydroxyapatite formulations (with or without home->care product association) were as effective as the other treatments in reducing dentin hypersensitivity over three months.
authors.forename: L
authors.initials: L
authors.lastname: Wang
authors.forename: A C
authors.initials: AC
authors.lastname: Magalhães
authors.forename: L F
authors.initials: LF
authors.lastname: Francisconi-Dos-Rios
authors.forename: M P
authors.initials: MP
authors.lastname: Calabria
authors.forename: Dfg
authors.initials: D
authors.lastname: Araújo
authors.forename: Mar
authors.initials: M
authors.lastname: Buzalaf
authors.forename: Jrp
authors.initials: J
authors.lastname: Lauris
authors.forename: J C
authors.initials: JC
authors.lastname: Pereira
mesh_terms: D000328:Adult; D057133:Dentin Desensitizing Agents / Q000627:therapeutic use*; D003807:Dentin Sensitivity / Q000628:therapy*; D004311:Double-Blind Method; D017886:Durapatite; D005260:Female; D005459:Fluorides; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010710:Phosphates; D012969:Sodium Fluoride; D014099:Toothbrushing; D014100:Toothpastes; D016896:Treatment Outcome
chemical_list: D057133:Dentin Desensitizing Agents; D010710:Phosphates; D014100:Toothpastes; D012969:Sodium Fluoride; D017886:Durapatite; D005459:Fluorides